Sign in to fuzzto save your conversations, follow your research and come back anytime.
Mahamaya Lifesciences
SectorChemicals
| Metric (₹ crore) | Q3 FY25 | Q4 FY25 |
|---|---|---|
| Sales | 0 | 119.52 |
| Expenses | 0 | 108.49 |
| EBITDA | 0 | 11.03 |
| Depreciation | 0 | 1 |
| EBIT | 0 | 10.03 |
| Interest | 0 | 3.26 |
| Profit Before Tax | 0 | 6.77 |
| Net Profit | 0 | 5.4 |
| EPS | 0 | 3.04 |
| Metric (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Operating Cash Flow | 2.16 | 1.12 | -22.57 | -0.43 | -29.52 |
| Investing Cash Flow | -3.25 | -2.85 | -2.09 | -7.14 | -15.6 |
| Financing Cash Flow | 1.38 | 2.36 | 24.35 | 8.55 | 80.52 |
| Net Cash Flow | 0.29 | 0.63 | -0.31 | 0.98 | 35.4 |
| Metric (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 15.71 | 19.44 | 24.66 | 49.42 | 121.93 |
| Total Liabilities | 40.01 | 58.44 | 87.41 | 138.93 | 188.35 |
| Total Assets | 55.71 | 77.88 | 112.07 | 188.35 | 310.28 |